Evaluation of plasma annexin V levels in children and young adults with solid tumors

Lahorte C.M. , Vanderheyden J.L. , Steinmetz N. , Van de Wiele C. , Dierckx R.A. , Slegers G. . Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 2004; 31: 887–919.

Kaneko N. , Matsuda R. , Hosoda S. , Kajita T. , Ohta Y. . Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 1996; 251: 65–80.

Matsuda R. , Kaneko N. , Kikuchi M. . Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room. Resuscitation 2003; 57: 171–7.

Rand J.H. , Arslan A.A. , Wu X.X. . Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 2006; 194: 182–8.

Van Heerde W.L. , Reutelingsperger C.P. , Maassen C. , Lux P. , Derksen R.H. , De Groot P.G. . The presence of antiphospho-lipid antibodies is not related to increased levels of annexin A5 in plasma. J Thromb Haemost 2003; 1: 532–6.

Peetz D. , Hafner G. , Blankenberg S. . Annexin V does not represent a diagnostic alternative to myoglobin for early detection of myocardial infarction. Clin Lab 2002; 48: 517–23.

Cohn S.L. , Pearson A.D. , London W.B. . The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009; 27: 289–97.

Cotterill S.J. , Ahrens S. , Paulussen M. . Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108–14.